Table 1.
Representative CXCR4 Antagonists and Agonists.
Name | Chemical Structure | Binding Activity (IC50, nM)b |
Migration Activity |
Calcium Mobilization |
Anti-HIV Activity (IC50, nM)c |
Type of Modulator and References |
|
---|---|---|---|---|---|---|---|
SDF-1α | 12G5 | ||||||
SDF-1α | KPVSLSYRCPCRFFESHVARANVK HLKILNTPNCALQIVARLKNNNRQ VCIDPKLKWIQEYLEKALNK |
4 | 20 | +f | + | 730 | Linear Peptide Modulator [171-175] |
ALX40-4C | Ac-NH-RRRRRRRRR-CONH2 | NDe | 3,200 | ND | − g | 3 | Linear Peptide Modulator [37, 43, 173] |
AMD3100 |
![]() |
33 | 37.5 | − | − | 12.4 | Orthosteric Modulator [46, 176, 177] |
AMD3465 |
![]() |
18 | 0.75 | − | − | 12.3 | Orthosteric Modulator [46, 177] |
AMD070 |
![]() |
13 | ND | ND | ND | 2 | Orthosteric Modulator [47, 178] |
KRH-3955 |
![]() |
0.61 | 2.8 | ND | − | 0.99 | Orthosteric Modulator [48] |
GSK812397 |
![]() |
0.87 | ND | − | − | 4.60 | Orthosteric Modulator [50] |
T22 |
![]() |
ND | 48 | ND | − | 5.1 | Cyclic/Orthosteric Modulator [51, 173] |
T140 | H-Arg-Arg-Nal-Cys-Tyr-Arg-Lys-D- Lys-Pro-Tyr-Arg-Cit-Cys-Arg-NH2a |
2.4 | 2.5 | − | − | 0.43 | Cyclic/Orthosteric Modulator [121, 130, 173, 179] |
TC14012 | H-Arg-Arg-Nal-Cys-Tyr-Cit-Lys-D- Cit-Pro-Tyr-Arg-Cit-Cys-Arg-NH2a |
2.9 | ND | − | ND | 37 | Cyclic/Orthosteric Modulator [130, 179] |
FC131 |
![]() |
4 | ND | ND | ND | 14 | Cyclic/Orthosteric Modulator [54, 55, 180-182] |
CGP64222 |
![]() |
ND | ND | ND | − | 1,386 1.8 (μg/ml) |
Orthosteric Modulator [57, 58] |
R3G |
![]() |
ND | 7,700 | ND | − | 15,000 | Orthosteric Modulator [183] |
NeoR |
![]() |
ND | ND | ND | ND | 800 | Orthosteric Modulator [184, 185] |
vMIP-II | LGASWHRPDKCCLGYQKRPLPQVL LSSWYPTSQLCSKPGVIFLTKRGR QVCADKSKDWVKKLMQQLPVTAR |
14.8 | 3.0 | ND | − | ND | Linear Peptide Modu- lator [38, 66, 67] |
V1 | LGASWHRPDKCCLGTQKRPLP | 190 | 640 | − | − | ND | Linear Peptide Modu- lator [38, 39, 62] |
DV1 | LGASWHRPDKCCLGYQKRPLP d | 13 | 32 | − | − | 12,100 | Linear Peptide Modu- lator [39, 78] |
RCP168 |
LGASWHRPDKCCLGYQKRPLPQVL LSSWYPTSQLCSKPGVIFLTKRGRQ VCADKSKDWVKKLMQQLPVTAR |
5 | 5 | − | − | 50 | Dimerized/Bivalent/ Orthosteric Modulator [68-70] |
RSVM | RSVMLSYRCPCRFFESH | ND | ND | + | + | ND | Allosteric Modulator [42, 186] |
ASLW | ASLWLSYRCPCRFFESH | ND | ND | + | + | ND | Allosteric Modulator [42, 186] |
DV1 Dimer |
![]() |
ND | 3 | ND | − | 4,400 | Dimerized/Bivalent/ Orthosteric Modulator [78] |
FC131 Analog |
![]() |
9.9 | ND | ND | ND | ND | Dimerized/Bivalent/ Orthosteric Modulator [187] |
CTCE-9908 |
![]() |
ND | ND | − | ND | ND | Dimerized/Bivalent/ Orthosteric Modulator [188-190] |
CXCL122 |
![]() |
166 | ND | − | + | ND | Dimerized/Bivalent/ Orthosteric Modulator [104, 174, 191] |
TN14003 | H-Arg-Arg-Nal-Cys-Tyr-Cit-Lys-D-Lys -Pro-Tyr-Arg-Cit-Cys-Arg-NH2a |
ND | ND | − | ND | 140 | Cyclic/Orthosteric Modulator [179, 192] |
BKT140 (4F- benzoyl -TN14003) |
4-fluorobenzoyl-Arg-Arg-Nal-Cys-Tyr-Cit- Lys-D-Lys-Pro-Tyr-Arg-Cit-Cys-Arg-NH2a |
0.99 | ND | − | − | ND | Cyclic/Orthosteric Modulator [130, 193] |
ATI-2341 | Palmitic acid-MGYQKKLRSMTDKYRL | ND | ND | + | + | ND | Linear Peptide Modu- lator [168, 194] |
Each peptide has a disulfide linkage between Cys4 and Cys13.
Competition binding assays utilized a single concentration of radioiodinated SDF-1α or monoclonal antibody 12G5 in the presence of various concentrations of unlabeled chemokines.
Infectious virus and/or single-cycle focal infective assays were performed to test the antiviral activities of CXCR4 inhibitors.
The D-amino acids are italicized.
ND: Not determined
+: Promotion
−: Inhibition